Clinical trial NCT05565053: Bilateral Erector Spinae Plane Block for Myofascial Pain Syndrome
Official title: Bilateral Erector Spinae Plane Block for Myofascial Pain Syndrome
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Myofascial Pain Syndrome
Keywords: Erector spinae plane block
Myofascial pain syndrome
Trigger point
Algometer
Visual Analog Scale
Pain
Lead sponsor: Istanbul University
Sponsor class: OTHER
First posted: 2022-10-04
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Comparing the efficacy of erector spina plan block and trigger point injection in patients with myofascial pain syndrome
Primary purpose: SCREENING

Brief summary: The investigators aimed to evaluate the effectiveness of bilateral erector spina plane block application in myofascial pain syndrome.

Detailed description: The investigators aimed to evaluate the effectiveness of bilateral erector spina plane block application in myofascial pain syndrome by comparing trigger point injection. Group 1 only one time erector spinae plane block and group 2 once a week total three times trigger point injection. Before the application, one week after application and one month after first application the investigators aimed to compare pressure pain threshold with algometer, visual analog scale score, short form-36 score, neck disability index score, beck depression scale score for the two groups. Each group has 30 participants, total 60 participants included this study. The investigators planned to show that bilateral erector spinae plane block can be used as an effective and safe method in the treatment of myofascial pain syndrome, since it is easier to apply than other invasive procedures used in the treatment and has a very low complication profile.

Eligibility criteria: Inclusion Criteria:

* Get a myofascial pain syndrome diagnosis
* No invasive procedure for myofascial pain syndrome in the last 1 month
* Signing the informed consent form

Exclusion Criteria:

* Cervical disc herniation
* Neck/shoulder, thoracal trauma or operation history
* Malignancy
* Kyphoscoliosis
* Inflammatory diseases (Rheumatoid arthritis, ankylosing spondylitis...)
* Congenital vertebral anomalies
* Neck pain with neurological deficit
* Pregnancy
* Mental, psychogenic disorder
* Hematological diseases that cause bleeding and coagulation disorders
* Use of antiplatelet, anticoagulant and drugs that cause bleeding tendency
* Severe systemic infection such as sepsis and local infection at the intervention site
* Having an allergy to any of the drugs to be used

Primary outcomes:
measure: Comparison of the effectiveness of the two interventions (trigger point injection versus Erector spinae plane block) assessed by Visual analog scale (VAS):
timeFrame: Baseline
measure: Comparison of the effectiveness of the two interventions (trigger point injection versus Erector spinae plane block) assessed by Visual analog scale (VAS):
timeFrame: 1. month
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul University Istanbul Faculty of Medicine
Study officials:
affiliation: Istanbul University
name: Halil Çetingök
role: STUDY_DIRECTOR
References: